Id |
Subject |
Object |
Predicate |
Lexical cue |
tok1 |
0-8 |
NNP |
denotes |
Progress |
tok2 |
9-12 |
CC |
denotes |
and |
tok3 |
13-22 |
NNS |
denotes |
Prospects |
tok4 |
23-25 |
IN |
denotes |
on |
tok5 |
26-33 |
NNP |
denotes |
Vaccine |
tok6 |
34-45 |
NNP |
denotes |
Development |
tok7 |
46-53 |
IN |
denotes |
against |
tok8 |
54-63 |
NNP |
denotes |
SARS-CoV- |
tok9 |
63-64 |
CD |
denotes |
2 |
tok10 |
64-65 |
. |
denotes |
. |
tok11 |
66-68 |
IN |
denotes |
In |
tok12 |
69-77 |
NNP |
denotes |
December |
lookup1 |
69-77 |
date |
denotes |
December |
tok13 |
78-82 |
CD |
denotes |
2019 |
lookup2 |
78-82 |
year |
denotes |
2019 |
tok14 |
82-83 |
, |
denotes |
, |
tok15 |
84-87 |
DT |
denotes |
the |
tok16 |
88-96 |
NN |
denotes |
outbreak |
tok17 |
97-99 |
IN |
denotes |
of |
tok18 |
100-109 |
NN |
denotes |
pneumonia |
tok19 |
110-116 |
VBN |
denotes |
caused |
event11 |
110-116 |
OCCURRENCE |
denotes |
caused |
tok20 |
117-119 |
IN |
denotes |
by |
lookup3 |
117-119 |
country_code |
denotes |
by |
tok21 |
120-121 |
DT |
denotes |
a |
tok22 |
122-127 |
NN |
denotes |
novel |
tok23 |
128-139 |
JJ |
denotes |
coronavirus |
tok24 |
139-140 |
, |
denotes |
, |
tok25 |
141-147 |
JJ |
denotes |
severe |
tok26 |
148-153 |
JJ |
denotes |
acute |
tok27 |
154-165 |
JJ |
denotes |
respiratory |
tok28 |
166-174 |
NN |
denotes |
syndrome |
tok29 |
175-186 |
JJ |
denotes |
coronavirus |
tok30 |
187-188 |
CD |
denotes |
2 |
tok31 |
189-190 |
( |
denotes |
( |
tok32 |
190-199 |
NNP |
denotes |
SARS-CoV- |
tok33 |
199-200 |
LS |
denotes |
2 |
tok34 |
200-201 |
) |
denotes |
) |
tok35 |
201-202 |
, |
denotes |
, |
tok36 |
203-206 |
VBZ |
denotes |
has |
tok37 |
207-210 |
VBN |
denotes |
led |
event1 |
207-210 |
OCCURRENCE |
denotes |
led |
tok38 |
211-213 |
TO |
denotes |
to |
lookup4 |
211-213 |
country_code |
denotes |
to |
tok39 |
214-215 |
DT |
denotes |
a |
tok40 |
216-223 |
JJ |
denotes |
serious |
tok41 |
224-232 |
JJ |
denotes |
pandemic |
tok42 |
233-235 |
IN |
denotes |
in |
lookup5 |
233-235 |
country_code |
denotes |
in |
tok43 |
236-241 |
NNP |
denotes |
China |
lookup6 |
236-241 |
location |
denotes |
China |
tok44 |
242-245 |
CC |
denotes |
and |
tok45 |
246-251 |
JJ |
denotes |
other |
tok46 |
252-261 |
NNS |
denotes |
countries |
tok47 |
262-271 |
NN |
denotes |
worldwide |
tok48 |
271-272 |
. |
denotes |
. |
tok49 |
273-275 |
RB |
denotes |
So |
lookup7 |
273-275 |
stop |
denotes |
So |
tok50 |
276-279 |
RB |
denotes |
far |
tok51 |
279-280 |
, |
denotes |
, |
tok52 |
281-285 |
JJR |
denotes |
more |
tok53 |
286-290 |
IN |
denotes |
than |
tok54 |
291-294 |
CD |
denotes |
460 |
tok55 |
294-295 |
, |
denotes |
, |
tok56 |
295-298 |
CD |
denotes |
000 |
tok57 |
299-308 |
VBD |
denotes |
confirmed |
event2 |
299-308 |
REPORTING |
denotes |
confirmed |
tok58 |
309-314 |
NNS |
denotes |
cases |
tok59 |
315-319 |
VBD |
denotes |
were |
tok60 |
320-329 |
VBN |
denotes |
diagnosed |
event3 |
320-329 |
OCCURRENCE |
denotes |
diagnosed |
tok61 |
330-332 |
IN |
denotes |
in |
lookup8 |
330-332 |
country_code |
denotes |
in |
tok62 |
333-339 |
RB |
denotes |
nearly |
tok63 |
340-343 |
CD |
denotes |
190 |
tok64 |
344-353 |
NNS |
denotes |
countries |
tok65 |
353-354 |
, |
denotes |
, |
tok66 |
355-362 |
VBG |
denotes |
causing |
event9 |
355-362 |
OCCURRENCE |
denotes |
causing |
tok67 |
363-371 |
RB |
denotes |
globally |
tok68 |
372-376 |
IN |
denotes |
over |
tok69 |
377-379 |
CD |
denotes |
20 |
tok70 |
379-380 |
, |
denotes |
, |
tok71 |
380-383 |
CD |
denotes |
000 |
tok72 |
384-390 |
NNS |
denotes |
deaths |
tok73 |
390-391 |
. |
denotes |
. |
tok74 |
392-401 |
RB |
denotes |
Currently |
tok75 |
401-402 |
, |
denotes |
, |
tok76 |
403-406 |
DT |
denotes |
the |
tok77 |
407-415 |
NN |
denotes |
epidemic |
tok78 |
416-418 |
VBZ |
denotes |
is |
lookup9 |
416-418 |
country_code |
denotes |
is |
tok79 |
419-424 |
RB |
denotes |
still |
tok80 |
425-434 |
VBG |
denotes |
spreading |
event10 |
425-434 |
OCCURRENCE |
denotes |
spreading |
tok81 |
435-438 |
CC |
denotes |
and |
tok82 |
439-444 |
EX |
denotes |
there |
tok83 |
445-447 |
VBZ |
denotes |
is |
lookup10 |
445-447 |
country_code |
denotes |
is |
tok84 |
448-450 |
DT |
denotes |
no |
lookup11 |
448-450 |
country_code |
denotes |
no |
tok85 |
451-460 |
JJ |
denotes |
effective |
tok86 |
461-466 |
VBZ |
denotes |
means |
tok87 |
467-469 |
TO |
denotes |
to |
lookup12 |
467-469 |
country_code |
denotes |
to |
tok88 |
470-477 |
VB |
denotes |
prevent |
event4 |
470-477 |
I_ACTION |
denotes |
prevent |
tok89 |
478-481 |
DT |
denotes |
the |
tok90 |
482-491 |
NN |
denotes |
infection |
tok91 |
491-492 |
. |
denotes |
. |
tok92 |
493-501 |
NNP |
denotes |
Vaccines |
tok93 |
502-505 |
VBP |
denotes |
are |
tok94 |
506-512 |
VBN |
denotes |
proved |
event8 |
506-512 |
I_STATE |
denotes |
proved |
tok95 |
513-515 |
TO |
denotes |
to |
lookup13 |
513-515 |
country_code |
denotes |
to |
tok96 |
516-518 |
VB |
denotes |
be |
lookup14 |
516-518 |
country_code |
denotes |
be |
tok97 |
519-522 |
DT |
denotes |
the |
tok98 |
523-527 |
RBS |
denotes |
most |
tok99 |
528-537 |
JJ |
denotes |
effective |
tok100 |
538-541 |
CC |
denotes |
and |
tok101 |
542-552 |
JJ |
denotes |
economical |
tok102 |
553-558 |
VBZ |
denotes |
means |
tok103 |
559-561 |
TO |
denotes |
to |
lookup15 |
559-561 |
country_code |
denotes |
to |
tok104 |
562-569 |
VB |
denotes |
prevent |
event5 |
562-569 |
I_ACTION |
denotes |
prevent |
tok105 |
570-573 |
CC |
denotes |
and |
tok106 |
574-581 |
VB |
denotes |
control |
tok107 |
582-592 |
JJ |
denotes |
infectious |
tok108 |
593-601 |
NNS |
denotes |
diseases |
tok109 |
601-602 |
. |
denotes |
. |
tok110 |
603-610 |
JJ |
denotes |
Several |
tok111 |
611-620 |
NNS |
denotes |
countries |
tok112 |
620-621 |
, |
denotes |
, |
tok113 |
622-631 |
NNS |
denotes |
companies |
tok114 |
631-632 |
, |
denotes |
, |
tok115 |
633-636 |
CC |
denotes |
and |
tok116 |
637-649 |
NNS |
denotes |
institutions |
tok117 |
650-659 |
VBD |
denotes |
announced |
event7 |
650-659 |
REPORTING |
denotes |
announced |
tok118 |
660-665 |
PRP$ |
denotes |
their |
tok119 |
666-674 |
NNS |
denotes |
programs |
tok120 |
675-678 |
CC |
denotes |
and |
tok121 |
679-687 |
NN |
denotes |
progress |
tok122 |
688-690 |
IN |
denotes |
on |
tok123 |
691-698 |
NN |
denotes |
vaccine |
tok124 |
699-710 |
NN |
denotes |
development |
tok125 |
711-718 |
IN |
denotes |
against |
tok126 |
719-722 |
DT |
denotes |
the |
tok127 |
723-728 |
NN |
denotes |
virus |
tok128 |
728-729 |
. |
denotes |
. |
tok129 |
730-735 |
IN |
denotes |
While |
tok130 |
736-740 |
JJS |
denotes |
most |
tok131 |
741-743 |
IN |
denotes |
of |
tok132 |
744-747 |
DT |
denotes |
the |
tok133 |
748-756 |
NNS |
denotes |
vaccines |
tok134 |
757-760 |
VBP |
denotes |
are |
tok135 |
761-766 |
IN |
denotes |
under |
tok136 |
767-773 |
NN |
denotes |
design |
tok137 |
774-777 |
CC |
denotes |
and |
tok138 |
778-789 |
NN |
denotes |
preparation |
tok139 |
789-790 |
, |
denotes |
, |
tok140 |
791-796 |
EX |
denotes |
there |
tok141 |
797-800 |
VBP |
denotes |
are |
tok142 |
801-805 |
DT |
denotes |
some |
tok143 |
806-810 |
WDT |
denotes |
that |
tok144 |
811-815 |
VBP |
denotes |
have |
tok145 |
816-823 |
VBN |
denotes |
entered |
event6 |
816-823 |
ASPECTUAL |
denotes |
entered |
tok146 |
824-832 |
NN |
denotes |
efficacy |
tok147 |
833-843 |
NN |
denotes |
evaluation |
tok148 |
844-846 |
IN |
denotes |
in |
lookup16 |
844-846 |
country_code |
denotes |
in |
tok149 |
847-854 |
NNS |
denotes |
animals |
tok150 |
855-858 |
CC |
denotes |
and |
tok151 |
859-866 |
JJ |
denotes |
initial |
tok152 |
867-875 |
JJ |
denotes |
clinical |
tok153 |
876-882 |
NNS |
denotes |
trials |
tok154 |
882-883 |
. |
denotes |
. |
tok155 |
884-888 |
DT |
denotes |
This |
lookup17 |
884-888 |
time_modifier |
denotes |
This |
tok156 |
889-895 |
NN |
denotes |
review |
tok157 |
896-902 |
RB |
denotes |
mainly |
tok158 |
903-910 |
VBD |
denotes |
focused |
event12 |
903-910 |
OCCURRENCE |
denotes |
focused |
tok159 |
911-913 |
IN |
denotes |
on |
tok160 |
914-917 |
DT |
denotes |
the |
tok161 |
918-926 |
NN |
denotes |
progress |
tok162 |
927-930 |
CC |
denotes |
and |
tok163 |
931-934 |
PRP$ |
denotes |
our |
tok164 |
935-944 |
NNS |
denotes |
prospects |
tok165 |
945-947 |
IN |
denotes |
on |
tok166 |
948-953 |
NN |
denotes |
field |
tok167 |
954-956 |
IN |
denotes |
of |
tok168 |
957-964 |
NN |
denotes |
vaccine |
tok169 |
965-976 |
NN |
denotes |
development |
tok170 |
977-984 |
IN |
denotes |
against |
tok171 |
985-994 |
NNP |
denotes |
SARS-CoV- |
tok172 |
994-995 |
CD |
denotes |
2 |
tok173 |
995-996 |
. |
denotes |
. |